A comparison of intermittent aortic cross clamping and intermittent aortic warm blood cardioplegia for myocardial protection during coronary artery bypass surgery
ISRCTN | ISRCTN43177829 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN43177829 |
Secondary identifying numbers | N0265006856 |
- Submission date
- 30/09/2005
- Registration date
- 30/09/2005
- Last edited
- 13/03/2014
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Mr JAJ Hyde
Scientific
Scientific
Cardiac Services
Queen Elizabeth Hospital
Birmingham
B15 2TH
United Kingdom
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Scientific title | |
Study objectives | Is the newer technique of intra-aortic warm blood cardioplegia superior to the established technique of intermittent aortic cross-clamping for myocardial protection during coronary surgery? |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Surgery: Coronary artery bypass grafting (CABG) |
Intervention | 40 patients undergoing elective CABG will randomly be allocated into two groups of 20 patients each, to receive either intermittent cross clamp with fibrillation (XCF) or intermittent warm blood cardioplegia (WBC). Blood will be taken from in-situ intra-arterial or intravenous cannulae, at the following 12 time points: Following induction of anaesthesia; Following institution of cardiopulmonary bypass, but prior to the application of an aortic cross clamp with resultant myocardial ischaemia; 30,60,90,120 minutes and 4,6,8,12,24,28 hours following final release of the aortic cross clamp. The blood will be centrifuged for serum, which will be stored frozen at -70C until batch analysis. The analysis will be performed blind. |
Intervention type | Procedure/Surgery |
Primary outcome measure | Not provided at time of registration |
Secondary outcome measures | Not provided at time of registration |
Overall study start date | 01/01/2004 |
Completion date | 01/01/2007 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Not Specified |
Sex | Not Specified |
Target number of participants | 40 |
Key inclusion criteria | Patients undergoing elective CABG |
Key exclusion criteria | Not provided at time of registration |
Date of first enrolment | 01/01/2004 |
Date of final enrolment | 01/01/2007 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Cardiac Services
Birmingham
B15 2TH
United Kingdom
B15 2TH
United Kingdom
Sponsor information
Department of Health
Government
Government
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
Phone | +44 (0)20 7307 2622 |
---|---|
dhmail@doh.gsi.org.uk | |
Website | http://www.dh.gov.uk/Home/fs/en |
Funders
Funder type
Government
University Hospital Birmingham NHS Trust (UK)
No information available
Research Funds
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |